Abstract
Purpose
Cardiac Troponins (cTnI, cTnT), NT-proBNP, and galectin-3 (GAL-3) mirror cardiomyocyte injury, stretch, and fibrosis. However, although these biomarkers has been thoroughly studied in marathon or ultramarathon, the effects occurring running shorter distances, as half-marathon, are less known and data are generally limited to immediately post-race evaluation. Moreover, significant variation of alpha-1 antitrypsin (AAT), an anti-protease factor with anti-inflammatory properties, has been recently observed in heart failure, but not investigated in paraphysiological settings. The aim of the study was to evaluate these biomarkers concentration and trends in trained runners before half-marathon run and during a 48-h recovery period.
Methods
In 18 half-marathon runners (15 males, 46 ± 6 years), cTnI, GAL-3 (Architect, Abbott), cTnT, NT-proBNP (Cobas e411, Roche), and AAT (Abcam, Cambridge, UK) were evaluated at rest, immediately post-run, and at 24 and 48-h recovery period.
Results
cTnT, NT-proBNP, and GAL-3 transiently increased after post-race, but normalized at 24 h (GAL-3 p < 0.01, cTnT < 0.001) or 48 h (NT-proBNP < 0.001), while cTnI and AAT did not significantly change. The frequency of values exceeding the diagnostic threshold, as evaluated at baseline and after the race, did not differ for cTnI (\({\chi ^{\text{2}}}\) = 1.1, p = ns), and NT-proBNP (\({\chi ^{\text{2}}}\) = 6, p = ns), but significantly increased for cTnT (\({\chi ^{\text{2}}}\) = 23, p < 0.001) and GAL-3 (\({\chi ^{\text{2}}}\) = 6.3, p < 0.05). None of the subjects showed AAT values exceeding the reference range at baseline and at any of the time points after the race.
Conclusion
The transient cTnT, NT-proBNP, and GAL-3 increase may suggest a temporary stress on the myocyte. However, being the increase of all biomarkers moderate and reversible, it may represent a physiological response to acute exercise.
Similar content being viewed by others
Abbreviations
- AAT:
-
α-1antitrypsin
- BMI:
-
Body mass index
- GAL-3:
-
Galactin-3
- HF:
-
Heart failure
- NT-proBNP:
-
N-terminal pro-brain natriuretic peptide
- cTnI:
-
Troponin I
- cTnT:
-
Troponin T
References
Abbate A, Van Tassell BW, Christopher S et al (2015) Effects of prolastin C (plasma-derived alpha-1 antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study). Am J Cardiol 115:8–12
Chatzianagnostou K, Del Turco S, Pingitore A et al (2015) The mediterranean lifestyle as a non-pharmacological and natural antioxidant for healthy aging. Antioxidants 4:719–736
Daniels LB, Maisel AS (2015) Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol 12:588–596
de Boer RA, van Veldhuisen DJ, Gansevoort RT et al (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272:55–64
de Boer RA, van der Velde AR, Mueller C et al (2014) Galectin-3: a modifiable risk factor in heart failure. Cardiovasc Drugs Ther 28:237–246
Eijsvogels TM, Hoogerwerf MD, Maessen MF et al (2015) Predictors of cardiac troponin release after a marathon. J Sci Med Sport 18:88–92
Gaggin HK, Januzzi JL Jr (2013) Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 1832:2442–2450
Gresslien T, Agewall S (2016) Troponin and exercise. Int J Cardiol 15:221:609–621
Hättasch R, Spethmann S, de Boer RA et al (2014) Galectin-3 increase in endurance athletes. Eur J Prev Cardiol 21:1192–1199
Kalsheker NA (1994) Molecular pathology of alpha 1-antitrypsin deficiency and its significance to clinical medicine. QJM 87:653–658
Knechtle B, Nikolaidis PT, Zingg MA et al (2016) Half-marathoners are younger and slower than marathoners. Springerplus 5:76
Kong Z, Nie J, Lin H, George K, Zhao G, Zhang H, Tong TK, Shi Q (2017) Sex differences in release of cardiac troponin T after endurance exercise. Biomarkers 22:345–350
Lee IM, Skerrett PJ (2001) Physical activity and all-cause mortality: what is the dose-response relation? Med Sci Sports Exerc 33:S459–S471
Lewis EC. Expanding the clinical indications for α(1)-antitrypsin therapy. (2012) Mol Med 18:957–970
Lippi G, Schena F, Salvagno GL, Montagnana M, Gelati M, Tarperi C, Banfi G, Guidi GC (2008) Influence of a half-marathon run on NT-proBNP and troponin T. Clin Lab 54:251–254
Lippi G, Schena F, Dipalo M et al (2012) Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run. Scand J Clin Lab Invest 72:467–470
Lubrano V, Papa A, Pingitore A, Cocci F (2017) α-1 protein evaluation to stratify heart failure patients. J Cardiovasc Med (Hagerstown) 18:774–776
Mattusch F, Dufaux B, Heine O, Mertens I, Rost R (2000) Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 21:21–24
Mehta R, Gaze D, Mohan S et al (2012) Post-exercise cardiac troponin release is related to exercise training history. Int J Sports Med 33:333–337
Middleton N, George K, Whyte G et al (2008) Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol 52:1813–1814
Nie J, George KP, Tong TK, Gaze D, Tian Y, Lin H, Shi Q (2011) The influence of a half-marathon race upon cardiac troponin T release in adolescent runners. Curr Med Chem 18:3452–3456
Niemelä M, Kangastupa P, Niemelä O, Bloigu R, Juvonen T (2016) Individual responses in biomarkers of health after marathon and half-marathon running: is age a factor in troponin changes? Scand J Clin Lab Invest 76:575–580
Pingitore A, Lima GP, Mastorci F et al (2015) Exercise and oxidative stress: potential effects of antioxidant dietary strategies in sports. Nutrition 31:916–922
Radak Z, Chung HY, Goto S (2008) Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med 44:153–159
Salvagno GL, Schena F, Gelati M et al (2014) The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon. Clin Chem Lab Med 52:267–272
Semple SJ, Smith LL, McKune AJ et al (2006) Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa. Br J Sports Med 40:124–127
Sun RR, Lu L, Liu M et al (2014) Biomarkers and heart disease. Eur Rev Med Pharmacol Sci 18:2927–2935
Tian Y, Nie J, Tong TK, Cao J, Gao Q, Man J, Shi Q, Liu W (2006) Changes in serum cardiac troponins following a 21-km run in junior male runners. J Sports Med Phys Fit 46:481–488
Tian Y, Nie J, Huang C, George KP (2012) The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes. J Appl Physiol (1985) 113:418–425
Tian Y, Nie J, George KP, Huang C (2014) Reproducibility of cardiac biomarkers response to prolonged treadmill exercise. Biomarkers 19:114–120
Tomaszewski M, Charchar FJ, Crawford L et al (2004) Serum C-reactive protein and lipids in ultraMarathon runners. Am J Cardiol 94:125–126
Vidotto C, Tschan H, Atamaniuk J, Pokan R, Bachl N, Müller MM (2005) Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes. Int J Sports Med 26:645–650
Acknowledgements
The authors wish to thank the athletes of “Gruppo Podistico Rossini http://www.podisticarossini.it” for the fundamental contribution to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Source of funding
None.
Additional information
Communicated by Keith Phillip George.
Rights and permissions
About this article
Cite this article
Vassalle, C., Masotti, S., Lubrano, V. et al. Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects. Eur J Appl Physiol 118, 411–417 (2018). https://doi.org/10.1007/s00421-017-3783-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-017-3783-x